NEUROBLASTOMA RECURRENT

This adverse event was reported 203 times

NEUROBLASTOMA RECURRENT is most prevalent among patients taking these drugs:

# Drug Count Frequency
0 DINUTUXIMAB 89 0.1036
1 IOBENGUANE I-123 5 0.0439
2 NAXITAMAB 8 0.0320
3 EFLORNITHINE HYDROCHLORIDE 1 0.0238
4 TOPOTECAN 27 0.0044
5 SARGRAMOSTIM 7 0.0040
6 TOPOTECAN HYDROCHLORIDE 6 0.0025
7 LORLATINIB 18 0.0024
8 ALDESLEUKIN 3 0.0024
9 DEXRAZOXANE FOR INJECTION 2 0.0021
See all drugs enriched for association with NEUROBLASTOMA RECURRENT